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summary
the aims of a clinical microbiology laboratory are rapid demonstration of pathogens from clinical samples and providing a 
dependable base for managing infections. three cases are discussed with aspects of rapid clinical diagnosis and application of 
molecular tools. Microscopic examination of positive blood cultures of septic patients demonstrated elongated bacterial forms 
which were identified as Escherichia coli within 4 hours by fluorescent in situ hybridization (fisH). irregular shape was attrib-
uted to previous administration of cefuroxime. in the second case, blood and urine cultures of a cancer patient yielded identical 
strains of E. coli and Enterococcus faecalis, as well. strains from blood were demonstrated and identified by the fisH method. 
pulsed field gel electrophoresis (pfge) demonstrated identity of isolates of different origin. We diagnosed sepsis provoked 
by pyelonephritis. in the third case, using a real time polymerase chain reaction (pcr) method, methicillin-resistant Staphylo-
coccus aureus (Mrsa) was detected from the wound infection of a patient who was infected by an Mrsa during his former 
hospitalization. pfge documented that these repeated isolates were different from all strains isolated in the same period from 
patients at the same ward, that is he was not re-infected after his second admission.
Key words: clinical microbiology, rapid diagnostics, molecular methods, infection control
IntroDUCtIon
Microbiology is the field of medical sciences which – 
through the in vitro examination of microorganisms and 
their effects on human health – is dedicated to support-
ing the management of infectious diseases including 
detection of pathogens either from clinical or screening 
samples, collection of data on antibiotic sensitivity, sur-
veillance of epidemics, vaccination and the study of mi-
croorganisms for future exploitation. the aims of these 
studies are diagnostic investigations of the clinical spec-
imens to identify infectious diseases and to ascertain 
their source, and particularly to establish an effective an-
timicrobial therapy. Clinical microbiology, confirming the 
previously stated clinical diagnosis, is closely related to 
the medical attendance. It aims to detect microorgan-
isms that could be accepted as causative or participat-
ing agents of an actually manifested infection. this de-
tection could be attained either directly (by culture or 
microscopically) or indirectly by demonstrating special 
products (i.e. antigens, toxins), components (individual 
nucleic acid sequences, protein fragments), or serologi-
cally detecting quality and quantity of antibodies pro-
duced against these compounds.
Microbiology examinations appear to establish activ-
ity of both infectology and clinical epidemiology, espe-
cially steps of infection control. Concerning diagnostic 
microbiology, the keystone remains detection of a living 
organism within another living organism, or in epide-
miological application, also from the inanimate environ-
ment. For that reason, clinical microbiology cannot be 
automated completely and remains time-consuming. 
the importance of rapid identification of pathogens 
from septic patients is of utmost importance to allow the 
clinician to start appropriate antibiotic therapy or scale 
down the broad spectrum antibiotic treatment already in 
progress. Delay in reporting laboratory (including micro-
biology) results may have a fatal outcome, above all in 
diagnostics of hazardous infections. the development 
in technological background of laboratory sciences of-
fers a more wide-ranging choice of molecular biology 
tools to help rapid and exact demonstration of several 
pathogens directly from clinical specimens or prelimi-
nary identification from the primoculture. A further re-
sponsibility of the microbiology expert is to evaluate the 
aetiological role of isolates before reporting. typing and 
comparison of isolates of different patients, or of the 
same patients but from different samples, or from ear-
lier periods of hospitalization, might clean  nosocomial 
selection of several clones or permanent persistence of 
a strain within the patient. Comparison of molecular pat-
terns of strains isolated from blood cultures, and from 
catheter tips (for example), is a rapid tool for the microbi-
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ologist to ascertain whether those were clinically relevant 
isolates or must be clarified as casual contaminants.
AIM
At Semmelweis University, due to centralization of di-
agnostic microbiology, operating a broad-spectrum clin-
ical microbiology profile completed with multifunctional 
(i.e. rapid diagnostic and basic epidemiological) molec-
ular biological service became practicable. Examples of 
the advantages of this complex laboratory background 
are presented in this paper.
MAtErIAl AnD MEtHoDS
Culture
Miscellaneous clinical samples obtained from outpa-
tients or patients admitted to university clinics, and, in 
addition, surveillance cultures and screening samples 
from admitted patients and staff members also were cul-
tured on Bio-rad culture media and were examined ac-
cording to the latest pertinent methodology guidelines. 
Urine samples were cultured on UriSelect4 chromoge-
nic agar plates (Bio-rad) and were evaluated according 
to the manufacturer’s recommendations. Isolated bac-
teria were identified by the Micronaut (Merlin) system. 
Antibiotic sensitivity was determined by the disk diffu-
sion method on Mueller-Hinton agar plates (Bio-rad), 
according to the ClSI recommendations (1).
Every step of the microbiology examination was per-
formed by the Central Clinical Microbiology Diagnostic 
laboratory of Semmelweis University, Budapest.
Detection of methicillin-resistant 
 Staphylococcus aureus (MRSA)
For MrSA screening, MrSASelect agar (Bio-rad) 
was used. Isolates from blood agar or from Mueller-Hin-
ton agar suspected MrSA were verified by Slidex MrSA 
Detection kit (bioMérieux). Directly from clinical samples, 
MrSA was detected by a real time PCr system using 
Xpert MRSA SStI kits (Cepheid) within a 53-min running 
period, according to the manufacturer’s instructions.
Blood cultures
Blood culture flasks were incubated in Bact/Alert 240 
system (bioMérieux). Flagged positive samples were ex-
amined microscopically after methylene blue and Gram 
staining, and were plated onto Columbia blood agar, 
Chocolate agar and Eosin-Methylene Blue agar plates 
(Bio-rad). Streptococcal antigens, when it was indicat-
ed, were detected by Pastorex Strep latex agglutination 
kit (Bio-rad) from supernatants of blood cultures.
Fluorescent in situ hybridization (FISH)
FISH-based bacterial identification (2) was performed 
directly on aliquots from positive specimens by the rapid 
BACtfish/BACtwave system (Izinta). Probes for identifi-
cation were chosen based on the Gram staining result. 
A Eubacteria probe reactive to every bacterium served 
as the process control.
10 µl aliquots of ten-fold diluted blood cultures were 
transferred onto BACtfish teflon covered slides and 
were dried at 45°C and fixed in a Bactwave microwave 
oven for 3 min. Permeabilization was carried out in cc 
methanol for 10 minutes.
In hybridization, tandem probes of a Gram negative 
sepsis kit (consisting of Enterobacteriaceae, Escherichia 
coli, Haemophilus influenzae, Klebsiella pneumoniae, 
Stenotrophomonas maltophilia, and Pseudomonas aerug-
inosa probes) and for identification of D group diplococci, 
Enterococcus faecalis and also E. faecium probes were 
used in ten-fold diluted solutions. A Eubacteria probe 
served as a positive (process) control. Incubation was 
completed in BACtwave for 16 min. Unbound probes 
were removed by washing plates in 30 ml of washing buf-
fer at 47°C for 12 min, rinsed in tap water and methanol, 
and dried at 47°C for 5 min. Every field of plates was cov-
ered with 3 µl of antifade reagent, covered with a cov-
erslip and examined with an epifluorescent microscope 
(olympus) supplied with Cy3, and FItC filters.
Pulsed field gel electrophoresis (PFGE)
Isolates of the same species but different clinical 
source were compared by pulsed field electrophoresis 
(PFGE). PFGE of Enterococcus faecalis strains was per-
formed in an agarose plug started from fresh blood agar 
cultures (3). Chromosomal DnA was digested by Sma I 
restriction endonuclease (Biolabs).
lysis of Escherichia coli cells, setting off overnight 
cultures, was carried out in agarose blocks (4). DnA 
was digested with Xba I endonuclease (Biolabs).
For MrSA typing, genomic DnA was prepared (5) 
and digested with Sma I restriction enzyme (Biolabs).
Agarose gel electrophoresis of digested DnA sam-
ples was performed in the CHEF-DrII (Bio-rad) sys-
tem. Detection and evaluation was accomplished by the 
GelDoc 2000Quantityone (Bio-rad) gel documentation 
system. lambda phage DnA and Staphylococcus au-
reus nCtC 8325 DnA were used as the molecular size 
control for E. faecalis, and digested Salmonella Brand-
erup DnA for E. coli strains, as well.
rESUltS
Case report 1
A 75-year-old female patient with previously diag-
nosed with Addison’s disease was admitted because 
of general deterioration, dyspnoea and weakness. Ini-
tial clinical, laboratory, and radiological investigations 
revealed no abnormal findings. Antibiotics were not 
administered. on the 3rd day of her hospitalization, 
the patient developed fever (38.6°C) and three pairs of 
blood cultures were obtained in twenty-minute intervals. 
thorax X-ray performed on the same day was normal. 
Control X-ray on the 6th day after admission showed 
pneumonia in the right lower lobe.
Both aerobic and anaerobic blood culture flasks 
turned out to be positive at the 10-12th hours of incuba-
tion. Microscopically, Gram negative, lengthened and 
swollen cells were observed with irregular form in size ex-
ceeding the bacterial range of size (fig. 1A). the internal 
control (Eubacteria probe) demonstrated bacterial infec-
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tion (fig. 1B). the test performed with specific probes for 
sepsis pathogens showed a positive E. coli result (fig. 1C) 
within two hours after a positive signal of blood cultures 
was noticed. Based on this preliminary result, consider-
ing also the patient’s multiple antibiotic hypersensitivity, 
cefuroxime administration was initiated. the next day, the 
preliminary report was confirmed since coliform colonies 
were isolated and identified as E. coli. In the antibiotic 
sensitivity test, the isolate was sensitive to all tested an-
tibiotics; the final result including antibiogram should be 
reported on the 3rd day of getting a positive signal.
Due to the appropriate administration of intravenous 
cefuroxime, the patient’s condition significantly im-
proved, having no fever. Although chest X-ray examina-
tion at the patient’s admission was negative, repeated 
image during the antibiotic treatment showed pneumo-
nia in the right lower lobe. Seven days after the antibiotic 
initiation there were no infiltrates in lungs and the patient 
was discharged in a satisfactory condition.
Before taking blood cultures, antibiotics were not 
administered in the ward. According to the patient’s 
account, before her admission she had taken antibiot-
ics sourced from a home reserve as she had done usu-
ally; therefore a prolonged post-antibiotic effect had to 
be considered. this assumption, namely formation of 
spheroplasts by the effect of a cell wall active antibiotic, 
would explain the irregular bacterial forms observed in 
microscopic slides from positive blood cultures.
Case report 2
A 64-year-old man, with a previous history of hyper-
tension and type 2 diabetes mellitus, and of rectal can-
cer neoplasia, was admitted to the Department of Cardi-
ology with the symptoms of a myocardial infarction for 
primary percutaneous coronary intervention (PCI).
During PCI, the right coronary artery was stented. the 
patient was in a satisfactory condition without signs of 
infection. on the third day of his hospital stay, extremely 
high temperature and shivering developed; serial blood 
cultures and urine cultures were obtained. Despite the 
combined antibiotic treatment (ceftriaxone and clarithro-
mycin), the patient had septic shock with acute orthos-
tatic hypotension, and kidney failure.
on the 3rd day, abdominal and pelvic ultrasound 
imaging were used to reveal the infection source. no 
abnormal findings on diagnostic imaging of liver, biliary 
tract, and pancreas were observed.
Size and structure of kidneys were average. on the 
right side, of the upper third, 7 mm echo-dense activity 
was detected. the pelvis showed a medium dilation.
the diagnosis of the ultrasound imaging was hepa-
tosplenomegaly with presumptive nephrolithiasis and 
pyelectasis. the ultrasound performed one week later 
confirmed a medium-sized cavernous dilation.
the urologist indicated a right-sided ureter catheter 
implantation. thereafter, strong diuresis was started. 
there was no stone, but debris was discharged through 
the catheter. Amoxycillin-clavulanic acid (3x 1.2 mg daily) 
was started after receiving the microbiology laboratory re-
ports. Since he had no fever, leukocytosis and renal func-
tion parameters normalized and his condition was satis-
factory after the ureteral catheterization and the antibiotic 
therapy, intravenous inotropic treatment was omitted.
Gram positive diplococci and also Gram negative 
rods were observed in positive blood cultures. Super-
natants of the flasks showed agglutination with Group D 
streptococcal reagent. the result of direct immunofluo-
rescent microscopy suggested presence of both E. coli 
and E. faecalis (fig. 2 A, B, C, D, E). the preliminary re-
sult was immediately reported to the ward.
on the same day, E. coli and E. faecalis with 106 cfu/ml 
were isolated from urine culture of the patient. Compar-
ing isolates of two sources by their antibiotic suscep-
tibility patterns, they seemed to be identical: E. coli 
isolates were sensitive to semisynthetic penicillins, car-
bapenems, cephalosporins, fluoroquinolones, doxycy-
cline, co-trimoxazole and also to aminoglycosides; and 
E. faecalis isolates were sensitive to amoxycillin, imi-
penem, vancomycin, ciprofloxacin, and intermediately 
to doxycycline, besides demonstrating a low rate of re-
sistance to gentamicin. During the judicious amoxycillin/
clavulanic acid therapy started with knowledge of the 
microbiology results, the patient’s parameters normal-
ized and on the fifth day his sepsis was cured.
By molecular comparison of DnA, samples served for 
clearing the hypothetical relation between isolates sourced 
from blood and urine (fig. 3). DnA fingerprints of strains 
originating from different clinical specimens proved to be 
identical. results of molecular typing of isolates confirmed 
acute pyelonephritis as the focus of sepsis.
Fig. 1. Microscopic examination of positive blood culture of case 1. light microscope, stained by methylene blue (A); Fluorescent 
in situ hybridization, reaction with Eubacteria probe (B) and Escherichia coli probe (C).
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Case report 3
A 63-year-old male patient was readmitted to the De-
partment of Vascular and Cardiac Surgery with a postoper-
ative wound infection. In his previous history, he underwent 
aorto-bifemoral (Dacron) bypass surgery 3 months earlier. 
After the positive MrSA report, the graft was removed; 
the patient was discharged without signs of infection. As 
he had fever 5 weeks after discharge he was re-admitted. 
MrSA screening tests (throat, nose) by a conventional 
(culture) method were negative. During his observation, 
he had no fever but inflammatory parameters were high 
and he complained of growing back pain. the periaortic 
abscess was surgically debrided. His conditions stabilized 
in the postoperative period. on the 6th postoperative day, 
MrSA was detected from the abdominal abscess by rt-
PCr, and also by simultaneous culture, E. coli, Klebsiella 
pneumoniae and Candida albicans were isolated. on the 
10th postoperative day he suddenly died. the most prob-
able cause of death was gastrointestinal bleeding originat-
ing from gastric ulcer of aorto-enteral fistula.
Genetic fingerprinting
Comparison of MrSA strains isolated from his ab-
dominal abscess and graft two months earlier, and of that 
obtained during his second hospitalization at the teach-
ing hospital, was carried out by PFGE technique. Figure 
4 demonstrates that patterns of the two isolates of the 
patient are identical but they differ from the MrSA isolates 
sourced from other patients in the same period.
DISCUSSIon
Diagnosis of sepsis
As an extreme manifestation of a blood stream in-
fection sepsis is a serious clinical condition, associated 
with high mortality, greater in patients with septic shock 
Fig. 2. Microscopic examination of positive blood culture of case 2. light microscope (A); Fluorescent in situ hybridization (B-E). 
A: Gram staining; B: Eubacteria probe; C: Enterobacteriaceae probe; D: Escherichia coli probe; E: Enterococcus faecalis probe.
Fig. 3. Comparison of macrorestriction profiles of Enterococ-
cus faecalis (A) and Escherichia coli (B) strains sourced from 
blood and urine cultures. Pulsed field gelelectrophoresis.
legends: 1. lambda phage DnA (control); 2. Enterococcus 
faecalis (urine); 3. Enterococcus faecalis (blood); 4. Staphylo-
coccus aureus nCtC 8325 (control); 5. Salmonella Branderup 
DnA (control); 6. Escherichia coli (urine); 7. Escherichia coli 
(blood).
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(40-70%) than in those with sepsis alone (25-30%) (6-8). 
According to the consensus conference description, 
sepsis is defined as systemic inflammatory response 
syndrome (SIrS) due to presumed or confirmed infec-
tion (7). In most cases, sepsis is a consequence of a 
local infection, giving pathogens an opportunity to enter 
the bloodstream, and cause systemic disease, with tac-
hypnoea, tachycardia, fever or hypothermia.
Septic patients may present with a variety of signs 
and symptoms. Diagnosis of sepsis requires complex ap-
proaches, including physical examination, search for signs 
of organ dysfunction and the possible source of infection, 
along with various laboratory tests, defining serum levels 
of biomarkers indicating serious inflammation, such as leu-
cocyte count and acute phase reactants. Blood cultures 
have a central role in diagnosis of bloodstream infections 
and confirmation of the microbial origin of the SIrS.
rapid diagnosis of sepsis is of utmost importance, re-
ducing mortality and length of hospitalization (8, 9). Be-
cause of the need for quick determination possibilities, 
several biomarkers, such as the acute-phase protein CrP 
(C-reactive protein), the level of which rises in the blood 
in response to inflammation, procalcitonin and activated 
partial thromboplastin time, are studied extensively as well 
(10, 11). these markers can indicate patients with sepsis 
among critically ill patients. However, blood cultures still 
remain the gold standard for detection of the causative 
pathogen and determination of the antibiotic sensitivity of 
the isolate, eventually for choosing a judicious therapy. A 
recent article underlined the importance of early adequate 
therapy versus empirical treatment: the mortality rate was 
67.8% for those patients who received inadequate therapy 
at admission to the intensive care unit, in contrast with 
28.7% mortality of the matched control group (12).
Microbiology testing of blood
In the past years, new molecular techniques have 
emerged for the detection of bloodstream infections, based 
on identification of bacterial and fungal antigens or nucleic 
acid fragments of the pathogens by various amplification 
and hybridization methods (13). However, these meth-
ods have some drawbacks, such as excessive specificity: 
most of the molecular techniques will only detect a narrow 
spectrum of pathogens, determining only the presence 
(or absence) of the questioned bacterium in the blood. In 
contrast, blood cultures have low specificity, and high sen-
sitivity, allowing detection of all microorganisms which may 
be present in the patient’s blood, and able to grow under 
the given conditions. By combining the two approaches 
their advantages add together: examination of flagged 
positive blood cultures with specific molecular techniques 
based on the microscopic morphology of the detected mi-
croorganisms enables rapid and specific determination of 
sepsis pathogens, enhancing early adequate therapy and 
improving prognosis of the disease.
Microbiology testing of blood samples is extremely 
sensitive to both clinical and laboratory conditions. If 
the patient received antimicrobial treatment before the 
sample for culture was taken, due to the presence of the 
drug the result of culture would be misleading: antibiot-
ics might kill or repress microorganisms, or especially 
in the presence of cell wall active antibiotics such as 
beta-lactam or glycopeptide derivatives irregular forms 
– protoplasts or spheroplasts – would be produced. 
these bacterial forms surrounded by only cell mem-
brane are extremely sensitive to the milieu; due to the 
osmotic pressure lysis of the cell occurs. these forms 
were detectable in blood cultures of our first patient. the 
early report followed only one hour after noticing positive 
a signal resulted not only in immediate administration of 
adequate therapy but it would be possible that lysis of 
spheroplasts yielded a false negative culture result on 
solid media for a longer incubation period.
Blood cultures have been indicated on the occasion of 
serious, life-threatening infections such as sepsis, pneu-
monia and meningitis. this underlines the significance of 
development of rapid diagnostic tools. the FISH method 
utilizes specific binding of fluorescent labelled oligonucle-
otide probes to target sequences situated on ribosomal 
rnA (2). While ribosomes exist in high copy numbers in 
dividing bacterial cells, during the logarithmic period, an 
amplification step – as in PCr – is not required for FISH. 
ten microorganisms in a field is regarded as a practical 
limit of detection in this test. the Eubacteria probe applied 
as an internal (positive) control is specific to highly con-
servative sequences of rrnA; therefore they can detect 
every bacterium. Because dead bacterial cells contain 
no detectable ribosomal rnA, in contrast to PCr, here 
only living (dividing) cells show a positive reaction which 
yields low incidence of false positivity.
the FISH method has been used in pathology, oncol-
ogy, genetic diagnostics and for examination of structural 
chromosome aberrations, but for microbiology, Delong 
and colleagues adapted it first (14). It is used more ex-
tensively to diagnose patients with sepsis, meningitis, 
wound infections or cystic fibrosis – especially when the 
need for rapid diagnosis is increased (15, 16). Detection 
Fig. 4. Pulsed field gelelectrophoretic (PFGE) image of me-
thicillin resistant Staphylococcus aureus strains isolated from 
inpatients of the Department of Vascular and Cardiac Surgery, 
Semmelweis University, Budapest.
legends: 1: BM wound, 20/07/2007; 2: BM wound, 14/09/2007; 
K: molecular mass control.
88 New Medicine 
3/2012
istván barcs et al.
time has been markedly (to only one hour) reduced using 
a special microwave oven for the hybridization step (2).
In our experience, the FISH method proved to be a 
helpful complementary test when identification deter-
mines the choice of therapy, when culture is not quick 
enough or is problematic, or the result is doubtful. re-
sults of immunofluorescence have been reported only 
as preliminary information and culture as a gold stan-
dard is not replaceable.
Source of sepsis
Multibacterial sepsis, i.e. presence of more than one 
relevant bacterial strain in one blood culture, occurs 
rarely, usually in an immunocompromised situation or in 
samples from patients who are in the final stage. In case 
2, diabetes and antitumour chemotherapy, as immuno-
suppressive factors, might contribute to the development 
of the septic stage. Blood and urine cultures yielded iden-
tical strains of E. coli, and E. faecalis, as well. the simulta-
neous incidence of two bacterial pathogens in his blood 
cultures was ascribed to this clinical situation.
Approximately 20-30% of hospital acquired sepsis 
cases are estimated to originate from the urogenital tract 
(17). the concept of urogenital sepsis expands from as-
ymptomatic bacteriuria to acute pyelonephritis related 
sepsis (18). In more than 50% of cases E. coli is the 
pathogen; in development and also in outcome of infec-
tion, virulence factors of the species, namely hemolysin 
production, adhesive fimbriae, iron binding systems, 
 K-capsular antigen and toxins, are decisive.
Urosepsis developing from pyelonephritis, in particular 
due to E. coli, occurs relatively frequently. Age (19) and 
primary biliary cirrhosis (20, 21) may contribute to the 
development of infection as predisposing factors in most 
cases. on the other hand, it is very rare that more than one 
bacterium is responsible for the infection, and etiological 
clarification of these cases is not free of difficulties.
to appreciate the clinical significance of urinary iso-
lates is subjective. In ascending lower tract infections, 
Enterobacteriaceae species, most frequently E. coli, and 
also enterococci derived from enteral flora, predomi-
nate (18). they usually cause monoinfection in cases 
of cystitis, and quantitatively, more than 105 cfu occur in 
millilitres of the spontaneously evacuated urine. on the 
other hand, the same species would contaminate urine 
samples collected without keeping the rules of speci-
men collection and personnel hygiene sourced from 
outer genitals. If more than one microorganism of pos-
sible enteral origin appears in high colony number in a 
urine culture it is usually regarded as contamination.
the phenomenon that the same species were isolat-
ed from blood and urine samples collected on the same 
day of the second patient indicated detailed compari-
son of the isolates. Molecular biological comparison is 
considered the “gold standard” in this respect. PFGE 
yields an individual pattern characteristic of every cell 
line; identical “fingerprint” means unambiguous identity 
of the tested strains (22-24). It was documented in our 
case comparing isolates from blood and urine. over and 
above that, this method can be used for propping up 
clinical relevance of occasional isolates: an identical pat-
tern of coagulase negative staphylococcal isolates from 
blood cultures and intravascular catheter tips confirms 
their pathogenic role but a difference in fingerprints pre-
cludes it (22, 24).
Advantages of molecular techniques
Application of molecular methods in clinical microbi-
ology practice facilitates rapid and exact detection and 
identification of pathogens either in culture or directly in 
specimens, and helps in detecting foci of infections or in 
verifying the clinical relevance of isolates by comparing 
them. For these reasons they are valuable accessories of 
the efficient diagnostic background of infectious diseases.
to treat systemic S. aureus infections only cell wall 
active antibiotics, i.e. penicillins or glycopeptides, 
would be administered. In management of MrSA sep-
sis, because of the complete cross-resistance between 
beta-lactams, there is no choice but to take glycopep-
tides (25). Because of the double mortality observed by 
glycopeptide treated patients compared to the oxacillin 
treated control group (26), early information on MrSA 
colonization or infection falls under the most consider-
able demands of the microbiology laboratory.
Spread of MrSA would be limited by hand hygiene 
regulations but its emergence can be prevented only by 
systemic and regular screening of both staff and newly 
admitted patients (27, 28). For forestalling horizontal 
transmission of an MrSA clone, a combination of tradi-
tional and molecular biology methods has been used. 
Performing screening tests by traditional culture methods 
or using chromogenic agar plates yields results within 48-
72 hours. to confirm the suspected MrSA colonies, ap-
plication of PBP2’ specific tests, detecting altered trans-
peptidase in penicillin-resistant cell wall is recommended. 
likewise, detection of the mecA gene encoding for PBP2’ 
production by PCr could be used to verify MrSA identi-
fication as a reference method (29, 30) but is insufficient 
to apply for direct detection of MrSA in swabs (31). For 
manifestation of methicillin resistance in the phenotype, 
functioning of fem factors (factor essential for methicillin 
resistance) is also essential. Accordingly, simultaneous 
detection of mecA and fem yields a more exact detec-
tion (32, 33). As these genes appear also in methicillin-
resistant coagulase negative staphylococci, validation of 
MrSA should be completed with detection of the nucA 
gene responsible for S. aureus-specific heat stable de-
oxyribonuclease production (33). this combination of 
amplification tests is not applicable for direct identification 
of MrSA from clinical samples or from screening tests be-
cause simultaneous presence of a methicillin-susceptible 
S. aureus (nucA) and a methicillin-resistant CnS (mecA) 
results in positivity with both tests and would be interpret-
ed as a positive (false positive) test (34).
the most efficient tools for direct detection of MrSA 
are considered real time PCr or immunomagnetic sepa-
ration of methicillin-resistant cells following a short pre-
incubation in an enrichment broth selective for MrSA 
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(27, 35). In our practice, GeneXpert (Cepheid) has been 
used for direct identification of MrSA in clinical samples 
when it was indicated. GeneXpert is dedicated to dem-
onstrating SCCmec (staphylococcal cassette chromo-
some mec) in a real time PCr cartridge with a sensitivity 
of 95% (36, 37). reaction time is 53-75 min, depending 
on the test chosen.
Indications of the test are estimated as follows 
 (38-40):
– Screening for MrSA carrier in high-risk patient 
groups, before admission to intensive care units;
–  rehospitalization of a patient with an anamnestic 
MrSA infection;
–  Ventilator-associated pneumonia; S. aureus bacter-
aemia, catheter related sepsis, prosthetic valve endo-
carditis;
–  Presumably S. aureus caused soft tissue infection in 
non-immunocompromised host;
–  Infections developed in connection with an MrSA en-
demic;
–  Every other situation indicated by an infectious dis-
ease specialist.
Efficacy of rapid diagnostic and screening test as well 
as molecular biology applications in clinical laboratory 
practice is well documented (27, 38, 41, 42). Considering 
the whole costs of hospitalization, cost-benefit calcula-
tions show rapid economic benefit of molecular methods 
because judicious therapy can be started earlier.
the raison d’être of simultaneous performance of 
classical microbiology examinations and also rapid 
tests needs no explaining. traditional culture methods 
are cheaper but yield results in days; therefore they are 
used for MrSA screening of occupational indication (la-
bour hygiene) or before vascular or elective orthopaedi-
atric surgery. PCr based tests are indicated in associ-
ated cases with critical care admission, cardiac surgery, 
and emergency orthopaedic surgery, as well (42).
Good examples for the beneficial scope of molecu-
lar methods and rapid diagnostics are provided by the 
results of case 3. the patient was earlier found to be 
MrSA positive as MrSA was isolated from his wound 
sample during his hospital stay in July 2007. Following a 
judicious vancomycin treatment, he was discharged in a 
stage apparently cured. two months later, at the time of 
his readmission, a PCr screening test was performed, 
according to the recent protocol, which yielded a posi-
tive result. Antibiogram of the S. aureus strain isolated 
from the simultaneous culture was identical to those of 
the previous one. Comparing these isolates by PFGE, 
they proved to be identical but both differed significantly 
from all of the MrSA isolates existing in the same period 
at the hospital. By molecular typing it could be demon-
strated that there was no direct infection of the patient 
by a new strain but he was re-infected by his own former 
pathogen, which involves different epidemiological and 
legal consequences.
Molecular tools have been indispensible elements of 
the recent clinical microbiology. In situ performed hy-
bridization and PCr tests directly from the specimen or 
from the blood culture flask provide a preliminary report 
through identification of the pathogens, and this could 
be a guide to start an appropriate anti-infective therapy 
(9, 43-45). the multifactorial comparison of bacterial 
and fungal isolates gives no prompt answer but in ab-
sence of typing tests, microbiology results could not be 
or could not unequivocally be interpreted occasionally. 
Accordingly, every microbiology department should en-
deavour to provide for prompt availability of examina-
tions of this sort either on the spot or in partnership.
ConClUSIon
It is indispensable that a diagnostic laboratory maxi-
mally fulfils its responsibility in the management of in-
fectious diseases. Quick and accurate demonstration 
of pathogens from clinical specimens must be a duty 
of the same significance as prediction or identification 
of health care associated epidemiological events is. 
traditional microbiology methods such as microscopy, 
culture, manual identification by visually evaluated tests 
and antibiotic sensitivity testing methods could not be 
or only partially be done by automated (instrumented) 
tools. However, the scope of (automated) molecular 
methods could be set even in daily diagnostic appli-
cations if the accuracy of laboratory activity and also 
cost-effectiveness of the medical attendance could be 
extended. It is self-evident that a laboratory department 
applies all diagnostic tools and examination profiles 
which are claimed and are beneficial for patients’ man-
agement because running costs are covered from the 
same budget. A problematic situation occurs when a di-
agnostic supplier does not organizationally or financially 
belong to the hospital or institute directly responsible 
for the patients’ care. In this case, reimbursement of the 
diagnostic services is reached between the supplier and 
the owner/operator realized by a bilateral agreement. 
It follows that preferences would differ and financing 
would be realized with a strong influence of health insur-
ance and moderated by local interests, namely implicitly 
must keep thrift in view, i.e. should be profitable.
In an effective health care system, the indicator of 
the effectiveness is the efficiency of healing. this could 
be converted into practice by contracts with health in-
surance companies, and, on the other hand, result in a 
decrease of functioning charges, by reducing antibiotic 
costs, hospitalization days and the frequency of suing 
for damages.
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